Rintaro Harada

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Takashi Uno2
Miho Watanabe Nemoto2
Aki Kanazawa2
Marie Kurokawa2
Gentaro Togasaki2
2Takashi Uno
2Miho Watanabe Nemoto
2Aki Kanazawa
2Marie Kurokawa
2Gentaro Togasaki
Learn More
In Japan, cetuximab with concurrent bioradiotherapy (BRT) for squamous cell carcinoma of head and neck (SCCHN) was approved in December 2012. We herein report our initial experience of BRT, with special emphasis on acute toxicities of this combination therapy. Thirty-one non-metastatic SCCHN patients who underwent BRT using cetuximab between July 2013 and(More)
The purpose of this study was to retrospectively evaluate the incidence of delayed renal dysfunction after total body irradiation (TBI) in long-term survivors of TBI/hematopoietic stem cell transplantation (HSCT). Between 1989 and 2006, 24 pediatric patients underwent TBI as part of the conditioning regimen for HSCT at Chiba University Hospital. Nine(More)
  • 1